Header image

Theme B Proffered Paper Session 3: Treatment

Tracks
.
Monday, September 24, 2018
4:00 PM - 5:35 PM
Grand Lodge (Level 1)

Speaker

Prof Andrew Carr
Senior Staff Specialist, HIV and Immunology Unit
St Vincent's Hospital, Sydney

Success And Failure Of Initial Antiretroviral Therapy (Art) In Adults: An Updated Systematic Review Including 77,999 Subjects From 1994 To 2017

4:00 PM - 4:15 PM

Abstract

Speaker Presentation

Biography

Dr Jillian Lau
Infectious Diseases Physician
Doherty Institute

Antiretroviral Treatment Interruptions In HIV Clinical Trials: A Systematic Review

4:15 PM - 4:30 PM

Abstract

Audio Recording

Speaker Presentation

Biography

Dr David Baker
Director
East Sydney Doctors

Durable Suppression 2 Years After Switch To Dolutegravir + Rilpivirine 2-Drug Regimen: Sword 1&2 Studies

4:30 PM - 4:45 PM

Abstract

Audio Recording

Speaker Presentation

Biography

Prof Don Smith
Senior staff Specialist
The Albion Centre

Switch To Bictegravir/F/TAF From DTG And ABC/3TC

4:45 PM - 5:00 PM

Abstract

Audio Recording

Speaker Presentation

Biography

Dr David Baker
Director
East Sydney Doctors

Phase 3 Randomised, Controlled Trial Of Switching To Fixed-Dose Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) From Boosted Protease Inhibitor-Based Regimens In Virologically Suppressed Adults: Week 48 Results

5:00 PM - 5:15 PM

Abstract

Audio Recording

Speaker Presentation

Biography

Rainer Puhr
Statistician
The Kirby Institute

Twenty Years Of Effective Antiretroviral Therapy: Investigating Response To Treatment And Changes In Treatment In Australia

5:15 PM - 5:30 PM

Abstract

Biography

Dr Timothy Barnes
General Practitioner
Holdsworth House Medical Practice

High HBV And HIV Suppression With Treatment Of HIV/HBV Coinfection In B/F/TAF Studies

5:30 PM - 5:35 PM

Abstract

Audio Recording

Speaker Presentation

Biography

Chair

Craig Cooper
Executive DIrector
Northern Territory AIDS & Hepatitis C Council

Kate Mackie
Senior Clinical Pharmacist
Burnet Institute

loading